Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
Mary V. Relling(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), James M. Boyett(University of Illinois Chicago), Michael L. Hancock(St. Jude Children's Research Hospital)
Cited by 383
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k